Outpatient care changes and associated mortality among Veterans with heart failure during the COVID-19 pandemic
PLOS One · 16.05.2025 · 20 (5) · e0323308
DOI: 10.1371/journal.pone.0323308 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 16.05.2025. Verfasst von Shilpa Vijayakumar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Imaging Program, Cardiovascular Division and Department of Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston,…. Hauptthemen laut MEDLINE: Heart Failure, COVID-19, Ambulatory Care, Veterans. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: U.S. Department of Veterans Affairs.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
The mortality risk associated with loss of in-person outpatient visits or transition to virtual care in patients with heart failure (HF) during the COVID-19 pandemic is unknown.
Objectives
Assess changes in outpatient HF care patterns and associated mortality.
Methods
Retrospective analysis of HF patients using national Veterans-Health-Administration (VHA) data. Among 509,511 HF patients who received VHA care, we compared mean monthly days-with-an-outpatient-visit from 2/2018–1/2020 (pre-COVID) versus 2/2020–1/2021 (COVID) using T-tests. In a subset of 321,439 patients with ≥1 VHA cardiology or primary-care visit in 2019, we related the presence and type of outpatient visit with mortality using Cox-Regression estimated hazard-ratios (HRs).
Results
Despite a 2–3-fold increase in video-only visits and use of telephone visits to maintain access, the overall days with outpatient visits decreased from a monthly-average of 81.4 ± 6.1 in 2018–2019 and 81.0 ± 5.6 in 2019–2020, to 57.8 ± 11 days in 2020–2021 (P < 0.01 for both), per 100 Veterans. When compared to patients with no-visits during the study period, the adjusted-mortality risk was lowest for patients with at least one in-person (HR 0.42, 95%CI: 0.41–0.44), followed by video-only (HR 0.52, 95%CI: 0.50–0.55) and then telephone-only (HR 0.57, 95%CI: 0.54–0.60) visits (p = 0.14 for trend). Results remained similar when the analysis was repeated (without including telephone visits) for pre-COVID (2/2018–1/2020) periods.
Conclusions
Despite an increase in video and use of telephone visits during the COVID-19 pandemic, there was still a decrease in total outpatient visits for patients with HF. The presence and type of outpatient encounter was associated with the adjusted risk of mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Cardiovascular Imaging Program, Cardiovascular Division and Department of Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.
- Center of Innovation, Providence VA Medical Center, Providence, Rhode Island, United States of America.
- Department of Medicine, Providence VA Medical Center, Alpert Medical School of Brown University, Providence, Rhode Island, United States of America.
ORCID-Profile: Shilpa Vijayakumar, Wen-Chih Wu
Förderung
- U.S. Department of Veterans Affairs
Zitieren
APA
Vijayakumar, S., Corneau, E., Erqou, S., Kokkirala, A., & Wu, W. C. (2025). Outpatient care changes and associated mortality among Veterans with heart failure during the COVID-19 pandemic. PLOS One, 20(5), e0323308. https://doi.org/10.1371/journal.pone.0323308
Vancouver
Vijayakumar S, Corneau E, Erqou S, Kokkirala A, Wu WC. Outpatient care changes and associated mortality among Veterans with heart failure during the COVID-19 pandemic. PLOS One. 2025;20(5):e0323308. doi:10.1371/journal.pone.0323308
BibTeX
@article{Vijayakumar2025,
author = {Vijayakumar, Shilpa and Corneau, Emily and Erqou, Sebhat and Kokkirala, Aravind and Wu, Wen-Chih},
title = {Outpatient care changes and associated mortality among Veterans with heart failure during the COVID-19 pandemic},
journal = {PLOS One},
year = {2025},
volume = {20},
number = {5},
pages = {e0323308},
doi = {10.1371/journal.pone.0323308}
}
EUVIMED